169 related articles for article (PubMed ID: 1430069)
1. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay.
Salimans MM; van Bussel MJ; Brown CS; Spaan WJ
J Virol Methods; 1992 Sep; 39(3):247-58. PubMed ID: 1430069
[TBL] [Abstract][Full Text] [Related]
2. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
Kock WC
J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
[TBL] [Abstract][Full Text] [Related]
3. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.
Gray JJ; Cohen BJ; Desselberger U
J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275
[TBL] [Abstract][Full Text] [Related]
4. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.
Heegaard ED; Qvortrup K; Christensen J
J Med Virol; 2002 Feb; 66(2):246-52. PubMed ID: 11782935
[TBL] [Abstract][Full Text] [Related]
5. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection.
Pereira RF; Paula WN; Cubel Rde C; Nascimento JP
Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423
[TBL] [Abstract][Full Text] [Related]
6. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
Kerr S; O'Keeffe G; Kilty C; Doyle S
J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
[TBL] [Abstract][Full Text] [Related]
7. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
Manaresi E; Zuffi E; Gallinella G; Gentilomi G; Zerbini M; Musiani M
J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
Chen MY; Lee KL; Hung CC
J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
[TBL] [Abstract][Full Text] [Related]
9. Use of recombinant human parvovirus B19 antigens in serological assays.
Cubie HA; Leslie EE; Smith S; O'Neill HJ; Hart H; Cohen BJ; Inglis JM
J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436
[TBL] [Abstract][Full Text] [Related]
10. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
Nunoue T
Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
[TBL] [Abstract][Full Text] [Related]
11. A recombinant immunoblot and ELISA for detection of acute parvovirus B19 infection.
Schwarz TF; Jäger G
Zentralbl Bakteriol; 1994 Mar; 280(4):526-33. PubMed ID: 8061414
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.
Jordan JA
J Clin Microbiol; 2000 Apr; 38(4):1472-5. PubMed ID: 10747128
[TBL] [Abstract][Full Text] [Related]
13. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.
von Poblotzki A; Hemauer A; Gigler A; Puchhammer-Stöckl E; Heinz FX; Pont J; Laczika K; Wolf H; Modrow S
J Infect Dis; 1995 Nov; 172(5):1356-9. PubMed ID: 7594677
[TBL] [Abstract][Full Text] [Related]
15. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
16. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen.
Brown CS; van Bussel MJ; Wassenaar AL; van Elsacker-Niele AM; Weiland HT; Salimans MM
J Virol Methods; 1990 Jul; 29(1):53-62. PubMed ID: 2170436
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
Nigro G; Luzi G; Fridell E; Ferrara M; Pisano P; Gattinara GC; Mezzaroma I; Söderlund M; Rasnoveanu D; Aiuti F
AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
[TBL] [Abstract][Full Text] [Related]
19. Detection of parvovirus B19 IgG: choice of antigens and serological tests.
Manaresi E; Gallinella G; Venturoli S; Zerbini M; Musiani M
J Clin Virol; 2004 Jan; 29(1):51-3. PubMed ID: 14675870
[TBL] [Abstract][Full Text] [Related]
20. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
Heegaard ED; Rasksen CJ; Christensen J
J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
